Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Acromegaly 2Prostatic Neoplasms 1Pituitary Neoplasms 1Neuroendocrine Tumors in Lung 1Neuroendocrine Tumors 1Neoplasm Metastasis 1Gigantism 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Carcinoid Tumor 1

Interventions

pasireotide 3lanreotide 1Temozolomide 1Rosiglitazone 1Pafolacianine 1Endoscopic Mucosal Resection 1Dexamethasone 1Capecitabine 1Calcium Dobesilate 1Cabergoline 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Pituitary Neoplasms × lanreotide × Clear all
NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡